Nobel laureate, two investment executives join Jackson Board of Trustees
| Date: September 3, 2008 |
Bar Harbor, Maine – Nobel laureate David Baltimore, Ph.D., and investment executives Marie Langlois, M.B.A., and Thomas Volpe, M.B.A., M.Sc., have joined The Jackson Laboratory’s Board of Trustees. The nonprofit research institution announced these and other board changes at its August 2008 annual meeting.
Dr. Baltimore’s association with The Jackson Laboratory goes back to his high school days. He and the late Howard Temin, with whom he shared the 1975 Nobel Prize in Medicine or Physiology, participated in the Laboratory’s Summer Student Program, and he credits that experience with launching his scientific career. Today Dr. Baltimore is president emeritus and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, where he is pursuing AIDS research.
(At a September 18 gala in New York, The Jackson Laboratory is also honoring Dr. Baltimore, together with Anthony B. Evnin, Ph.D., with lifetime achievement awards. Dr. Evnin is a general partner of Venrock.)
Marie J. Langlois is the managing director and co-founder of Washington Trust Investors, a division of Washington Trust Company. A chartered financial analyst and one of the first women to earn an M.B.A. from Harvard Business School, she has 30 years’ experience as an investment professional for individuals, institutions and corporations. She is an active community leader who advises several nonprofit organizations, including her alma mater, Brown University.
Thomas S. Volpe is the chief executive officer and member of the board of directors of the Dubai Group, Dubai, U.A.E. He was the CEO and founder of Volpe Investments, L.L.C., a private equity investment firm in Menlo Park, Calif. Mr. Volpe serves as a director for several corporations and is the owner, chair and CEO of two minor-league baseball teams. Mr. Volpe holds an M.B.A. from the Harvard Business School, a M.Sc. in economics from the London School of Economics, and an A.B. in economics from Harvard University.
Two Jackson trustees whose terms were renewed at the annual meeting are Leo A. Holt and Sam R. Little. Mr. Holt is president of Holt Logistics Corp., a marine terminal and logistics systems developer and operator that is part of a family-owned group based in Philadelphia, Pa. Mr. Little is a registered architect at Boles, Smyth Associates, with a professional focus on transportation, transit and environmental planning; he is a grandson of Jackson Laboratory founder Clarence Cook Little.
Daniel R. Tishman of New York was named a trustee emeritus of the Laboratory. Mr. Tishman is chairman and CEO of Tishman Construction Corporation, one of the nation’s largest and most experienced builders and developers. Newly named honorary trustees of the Laboratory are Dwight E. Lee, a portfolio manager with Gagnon Securities, LLC in New York, and Nancy J. Kelley, J.D., M.P.P., a Boston-area independent consultant and advisor to healthcare and life science companies.
The Jackson Laboratory is a nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center based in Bar Harbor, Maine. Its mission is to discover the genetic basis for preventing, treating and curing human diseases, and to enable research and education for the global biomedical community.
# # #
Contact(s): Joyce Peterson, 207-288-6058
For information on automatic email delivery of news releases (journalists only), please send an email request for details to news@jax.org. Please address other inquiries to pubinfo@jax.org.
Media Relations, Communications Office
The Jackson Laboratory
600 Main Street
Bar Harbor, Maine 04609-1500
Phone: 207-288-6058 (journalists only)
Main Jackson Laboratory phone: 207-288-6000
Fax: 207-288-6076
Email: news@jax.org
